Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
140.90
+0.77 (0.55%)
Mar 9, 2026, 3:09 PM EDT - Market open

Insmed Market Cap

Insmed has a market cap or net worth of $30.37 billion as of March 9, 2026. Its market cap has increased by 100.69% in one year.

Market Cap
30.37B
Enterprise Value
30.04B
1-Year Change
100.69%
Ranking
Category
Stock Price
$140.90

Market Cap Chart

Since June 1, 2000, Insmed's market cap has increased from $409.10M to $30.37B, an increase of 7,323.92%. That is a compound annual growth rate of 18.19%.

History

DateMarket Cap% Change
Mar 6, 202630.21B-18.62%
Dec 31, 202537.12B200.52%
Dec 31, 202412.35B178.59%
Dec 29, 20234.43B63.79%
Dec 30, 20222.71B-16.06%
Dec 31, 20213.22B-4.92%
Dec 31, 20203.39B58.95%
Dec 31, 20192.13B110.95%
Dec 31, 20181.01B-57.65%
Dec 29, 20172.39B191.73%
Dec 30, 2016818.60M-27.02%
Dec 31, 20151.12B46.00%
Dec 31, 2014768.30M15.55%
Dec 31, 2013664.90M217.07%
Dec 31, 2012209.70M177.01%
Dec 30, 201175.70M-7.91%
Dec 31, 201082.20M-18.05%
Dec 31, 2009100.30M75.35%
Dec 31, 200857.20M-43.08%
Dec 31, 2007100.50M13.95%
Dec 29, 200688.20M-17.72%
Dec 30, 2005107.20M26.86%
Dec 31, 200484.50M-25.88%
Dec 31, 2003114.00M665.10%
Dec 31, 200214.90M-88.15%
View and export this data all the way back to 2000. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
argenx SE 44.16B
Alnylam Pharmaceuticals 42.53B
BeOne Medicines AG 33.41B
Royalty Pharma 26.20B
BioNTech SE 25.47B
Moderna 20.74B
Roivant Sciences 20.60B
Revolution Medicines 19.50B
Market Cap Rankings